Working together to improve patient care is our credo. This year at the 13th European Multidisciplinary Congress on Urological Cancers (EMUC21), we will place more emphasis on the importance of multi-sectoral approach when offering the best care to patients.
The EMUC21 scientific programme will comprise of contemporary relevant developments in the prevention, diagnosis and management of genito-urinary (GU) cancers. Its scope will include the new WHO classification of GU cancers, modern imaging in prostate cancer, integrating systemic therapy in non-muscle-invasive bladder cancer, updates on major trials, recent molecular developments in the field, and more.